Sigma Investment Counselors Inc Amgen Inc Transaction History

Sigma Investment Counselors Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	SELL	$219.27 - $242.57 $1,973 - $2,183	-9 Reduced 0.97%	919 $222,000
Q4 2021 Feb 08, 2022	BUY	$198.88 - $227.6 $184,560 - $211,212	928 New	928 $209,000
Q3 2021 Nov 05, 2021	SELL	$212.27 - $248.7 $195,076 - $228,555	-919 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$233.58 - $259.14 $5,605 - $6,219	24 Added 2.68%	919 $224,000
Q1 2021 Apr 30, 2021	SELL	$221.91 - $258.6 $4,438 - $5,172	-20 Reduced 2.19%	895 $223,000
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $8,438 - $10,049	39 Added 4.45%	915 $210,000
Q3 2020 Oct 20, 2020	BUY	$234.65 - $260.95 $205,553 - $228,592	876 New	876 $223,000
Q1 2020 Apr 22, 2020	SELL	$182.24 - $241.7 $155,450 - $206,170	-853 Closed	0 $0
Q4 2019 Jan 21, 2020	BUY	$189.21 - $243.2 $161,396 - $207,449	853 New	853 $206,000
Q3 2018 Oct 23, 2018	SELL	$185.29 - $208.89 $204,004 - $229,987	-1,101 Closed	0 $0
Q2 2018 Jul 24, 2018	BUY	$166.05 - $186.51 $182,821 - $205,347	1,101 New	1,101 $203,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Sigma Investment Counselors Inc, based on Form 13F filings with the SEC.

Stay updated on Sigma Investment Counselors Inc with notifications on news.